- TWD7.16bn
- TWD11.02bn
- TWD3.88bn
- 65
- 52
- 16
- 38
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,950 | 2,555 | 2,440 | 2,974 | 3,877 |
Cost of Revenue | |||||
Gross Profit | 806 | 831 | 849 | 902 | 1,068 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2,433 | 2,042 | 1,946 | 2,499 | 3,264 |
Operating Profit | 517 | 513 | 493 | 476 | 613 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 477 | 464 | 491 | 484 | 559 |
Provision for Income Taxes | |||||
Net Income After Taxes | 390 | 363 | 380 | 389 | 425 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 395 | 366 | 382 | 357 | 419 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 418 | 394 | 405 | 379 | 438 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.54 | 1.96 | 2.18 | 2.19 | 2.27 |
Dividends per Share |